Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer
Open Access
- 13 April 2023
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 12 (4) , 926
Abstract
The potential use of agomelatine as an alternative treatment for colorectal cancer is evaluated in this work. The effect of agomelatine was studied in an in vitro model using two cell lines with different p53 statuses (HCT-116, wild-type p53, and HCT-116 p53 null) and an in vivo xenograft model. The inhibitory effects of agomelatine and melatonin were stronger in the cells harboring the wild-type p53, although in both cell lines, the effect of agomelatine was greater than that of the melatonin. In vivo, only agomelatine was able to reduce the volumes of tumors generated by the HCT-116-p53-null cells. Both treatments induced changes in the rhythmicity of the circadian-clock genes in vitro, albeit with some differences. Agomelatine and melatonin regulated the rhythmicity of Per1-3, Cry1, Sirt1, and Prx1 in the HCT-116 cells. In these cells, agomelatine also regulated Bmal1 and Nr1d2, while melatonin changed the rhythmicity of Clock. In the HCT-116-p53-null cells, agomelatine regulated Per1-3, Cry1, Clock, Nr1d2, Sirt1, and Prx1; however, melatonin only induced changes in Clock, Bmal1, and Sirt1. The differences found in the regulation of the clock genes may explain the greater oncostatic effect of agomelatine in CRC.Keywords
Funding Information
- Instituto de Salud Carlos III- Feder (PI18/01947, PI-067/2013, C-0033-2015, FPU190/02269)
- Junta de Andalucía (PI18/01947, PI-067/2013, C-0033-2015, FPU190/02269)
- Andalusian Health Service (PI18/01947, PI-067/2013, C-0033-2015, FPU190/02269)
- Ministerio de Universidades (Spain) (PI18/01947, PI-067/2013, C-0033-2015, FPU190/02269)
This publication has 59 references indexed in Scilit:
- Peroxiredoxins are conserved markers of circadian rhythmsNature, 2012
- Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult ratsInternational Journal of Neuropsychopharmacology, 2012
- Synergistic mechanisms involved in the antidepressant effects of agomelatineEuropean Neuropsychopharmacology, 2012
- The melatonin action on stromal stem cells within pericryptal area in colon cancer model under constant lightBiochemical and Biophysical Research Communications, 2011
- Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancerJournal of Pineal Research, 2009
- Circadian Control of the NAD + Salvage Pathway by CLOCK-SIRT1Science, 2009
- The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian ControlCell, 2008
- SIRT1 Regulates Circadian Clock Gene Expression through PER2 DeacetylationCell, 2008
- 5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein InteractionJournal of Biological Chemistry, 2007
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999